S. 516 (113th): PROSTATE Act

Introduced:

Mar 11, 2013
113th Congress, 2013–2015

Status:
Died in a previous Congress

This bill was introduced on March 11, 2013, in a previous session of Congress, but was not enacted.

Sponsor:

Jon Tester

Senior Senator from Montana

Democrat

Text:

Read Text »
Last Updated: Mar 11, 2013
Length: 17 pages

About the bill

Full Title

A bill to reduce disparities and improve access to effective and cost efficient diagnosis and treatment of prostate cancer through advances in testing, research, and education, including through telehealth, comparative effectiveness research, and identification of best practices in patient education and outreach particularly with respect to underserved racial, ethnic and rural populations and men with a family history of prostate cancer, to establish a directive on what constitutes clinically appropriate prostate cancer imaging, and to create a prostate cancer scientific advisory board for the Office of the Chief Scientist at the Food and Drug Administration to accelerate real-time sharing of the latest research and accelerate movement of new medicines to patients.

The bill’s titles are written by its sponsor.

Read CRS Summary >

History

Mar 11, 2013
 
Introduced

This is the first step in the legislative process.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: